Wu Zheng-Jie, Zhao Wang-Lin, Zeng Yan-Hui, Zhu Yong-Zhan, Ou Jin-Yan
Department of Orthopaedics and Traumatology, Foshan Hospital of Traditional Chinese Medicine, Foshan 528000, Guangdong, China.
Zhongguo Gu Shang. 2010 Jul;23(7):500-3.
To explore the effects of Tongmai decoction on the perioperative changes of serum concentrations of tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-6 in patients with femoral fractures, and conform the effectiveness of Tongmai decoction on inflammatory factors in patients with femoral fractures, providing the theoretical evidence for the clinical use of Tongmai decoction.
From October 2007 to May 2009, 60 patients with closed traumatic femoral fractures were selected according to the inclusion criterias and exclusion criterias. All the patients were randomly divided into three groups (group A, group B and group C). Twenty patients in group A (Tpanax Notoginseng pill group), 13 patients were male and 7 patients were female; ranging in age from 20 to 45 years, averaged 32.0 years; the disease course ranged from 2.0 to 26.0 h, with an average of 9.5 h. Twenty patients in group B (Tpanax Notoginseng pills and Lornoxicam injection group),12 patients were male and 8 patients were female; ranging in age from 23 to 42 years, averaged 31.0 years; the disease course ranged from 3.5 to 25.0 h, with an average of 13.6 h. Twenty patients in group C (Tpanax Notoginseng pill, Lornoxicam injection and Tongmai decoction group), 14 patients were male and 6 patients were female; ranging in age from 21 to 44 years, averaged 31.5 years; the disease course ranged from 4.6 to 29.0 h, with an average of 13.3 h. Among all the patients, 42 patients with fractures were fixed with femoral intramedullary nailing, and other 18 patients with femoral locking plate fixation. The patients in group A took Tpanax Notoginseng pills orally, 4 g each time and twice daily; the patients in group B took Tpanax Notoginseng pills orally as group A, and at the same time received intramuscular injection of Lornoxicam, 8 mg each time and once daily; the patients in group C took Tpanax Notoginseng pills orally and received intramuscular injection of Lornoxicam as group B, and at the same time took Tongmai decoction (R ) orally, 200 ml each time and twice daily. The above medications were administered to the three groups on the second day after admission to hospital. Peripheral blood samples were taken for determination of pro-inflammatory cytokines of TNF-alpha and IL-6 in blood serum on the 2nd and 6th days before operation and on the 8th and 13th days after operation. And all the patients were evaluated liver and kidney function at the 2nd and 7th days after admission. Analysis of variance and least significant difference-test were done with the help of SPSS 17.0 statistic software.
The differences among three groups of TNF-alpha and IL-6 in blood serum at the 2nd day after admission and 2 days after operation had no statistical significance (P > 0.05). The TNF-alpha and IL-6 levels among 3 groups had statistical differences at the 7th day after admission and at the 7th day after operation (P < 0.05, P < 0.01). There were significant differences of TNF-alpha and IL-6 levels between the 7th day after admission and the 2nd day after admission, the 7th day after operation and the 2nd day after admission (P < 0.01). There were also significant differences of TNF-alpha and IL-6 levels between group C compared with group A and B at the 7th day after admission and the 7th day after operation(P < 0.05, P < 0.01).
The serum concentrations of TNF-alpha and IL-6 level significantly increased in perioperative period. The results indicate that the Tongmai decoction may play an important role in inhibiting the release of TNF-alpha and IL-6 into the blood stream and decreasing the incunabula complication at early traumatic stage.
探讨通脉汤对股骨骨折患者围手术期血清肿瘤坏死因子α(TNF-α)及白细胞介素(IL)-6浓度变化的影响,验证通脉汤对股骨骨折患者炎症因子的作用,为通脉汤临床应用提供理论依据。
选取2007年10月至2009年5月符合纳入标准及排除标准的60例闭合性创伤性股骨骨折患者,随机分为三组(A组、B组和C组)。A组20例(三七丸组),男13例,女7例;年龄20~45岁,平均32.0岁;病程2.0~26.0小时,平均9.5小时。B组20例(三七丸与氯诺昔康注射液组),男12例,女8例;年龄23~42岁,平均31.0岁;病程3.5~25.0小时,平均13.6小时。C组20例(三七丸、氯诺昔康注射液与通脉汤组),男14例,女6例;年龄21~44岁,平均31.5岁;病程4.6~29.0小时,平均13.3小时。60例患者中,42例骨折采用股骨带锁髓内钉固定,18例采用股骨锁定钢板固定。A组患者口服三七丸,每次4 g,每日2次;B组患者口服三七丸同A组,同时肌内注射氯诺昔康,每次8 mg,每日1次;C组患者口服三七丸及肌内注射氯诺昔康同B组,同时口服通脉汤(方剂),每次200 ml,每日2次。上述药物于入院后第2天开始对三组患者进行给药。分别于术前第2天、第6天及术后第8天、第13天采集外周血样本测定血清中促炎细胞因子TNF-α及IL-6。并于入院后第2天、第7天对所有患者进行肝肾功能评估。借助SPSS 17.0统计软件进行方差分析及最小显著差检验。
入院后第2天及术后2天三组血清TNF-α及IL-6差异无统计学意义(P>0.05)。入院后第7天及术后第7天三组TNF-α及IL-6水平有统计学差异(P<0.05,P<0.01)。入院后第7天与入院后第2天、术后第7天与入院后第2天TNF-α及IL-6水平比较差异有统计学意义(P<0.01)。入院后第7天及术后第7天C组与A组、B组比较TNF-α及IL-6水平差异有统计学意义(P<0.05,P<0.01)。
围手术期血清TNF-α及IL-6水平显著升高。结果表明通脉汤可能在抑制TNF-α及IL-6释放入血流及降低早期创伤阶段潜在并发症方面发挥重要作用。